Home Research Feeds Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

Genomic analysis identifies association of Fusobacterium with colorectal carcinomaOriginal paper

Researched by:

  • Karen Pendergrass

Last Updated: 2026-07-05

Karen Pendergrass
Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Read More
Location
Spain
Sample Site
Colon
Species
Homo sapiens

What was studied?

The study characterized the microbiota of colorectal carcinoma to assess whether specific microbial community changes are associated with the tumor microenvironment. It used a genomics-first approach, profiling tumor tissue against matched normal tissue and validating candidate organisms with independent molecular methods.

Who was studied?

The discovery set consisted of whole genome sequences from nine colorectal tumor/normal tissue pairs. Findings were then validated in 95 carcinoma/normal DNA pairs using quantitative PCR and 16S rDNA sequence analysis, with additional in situ confirmation by fluorescence in situ hybridization (FISH).

What were the most important findings?

Fusobacterium sequences were enriched in carcinomas relative to matched normal tissue, a result confirmed by quantitative PCR and 16S rDNA sequencing, whereas the Bacteroidetes and Firmicutes phyla were depleted in tumors. Fusobacteria were also directly visualized within colorectal tumors by FISH, supporting their physical presence in the tumor tissue.

What are the greatest implications of this study?

The authors conclude that colorectal cancer is associated with distinct alterations in the tumor microbiota, notably Fusobacterium enrichment. Because this is an observational, association-based analysis, causation is not established, and the authors state that the precise role of Fusobacteria in colorectal carcinoma pathogenesis requires further investigation.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Join the Waitlist and help shape the future of microbiome medicine.